Pacific Biosciences Of California (PACB) Non Operating Income (2010 - 2026)
Pacific Biosciences Of California's quarterly Non Operating Income came in at $2.0 million in Q1 2026, down 53.28% year-on-year from $4.3 million in Q1 2025, and down 27.53% quarter-over-quarter from $2.8 million in Q4 2025.
Pacific Biosciences Of California has reported Non Operating Income for 17 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 53.28% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.5 million (down 41.51% YoY), and the FY2025 full-year result was $14.8 million, down 37.95% from the prior year.
- Non Operating Income for Q1 2026 stood at $2.0 million, down from $2.8 million in the prior quarter.
- The five-year high for Non Operating Income was $8.9 million in Q2 2023, with the low at -$279000.0 in Q1 2022.
- Average Non Operating Income over 5 years is $4.8 million, with a median of $4.7 million recorded in 2025.
- Peak annual rise in Non Operating Income reached 634700.0% in 2022, while the deepest fall reached 535.94% in 2022.
- Tracing PACB's Non Operating Income over 5 years: stood at $6.3 million in 2022, then jumped by 32.06% to $8.4 million in 2023, then sank by 51.51% to $4.1 million in 2024, then plunged by 31.91% to $2.8 million in 2025, then dropped by 27.53% to $2.0 million in 2026.
- The last three Non Operating Income figures came in at $2.0 million (Q1 2026), $2.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.01 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.29 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 6.76 Mn |
| Dec 31, 2023 | 8.38 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 8.93 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 6.35 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | -279,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 161,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 98.00 Mn |
| Sep 30, 2020 | 467,000.00 |
| Jun 30, 2020 | 438,000.00 |
| Mar 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 504,000.00 |
| Sep 30, 2019 | -345,000.00 |
| Jun 30, 2019 | 428,000.00 |
| Mar 31, 2019 | 435,000.00 |
| Dec 31, 2018 | 452,000.00 |
| Sep 30, 2018 | 242,000.00 |
| Jun 30, 2018 | -197,000.00 |
| Mar 31, 2018 | 351,000.00 |
| Dec 31, 2017 | 391,000.00 |
| Sep 30, 2017 | 181,000.00 |
| Jun 30, 2017 | -326,000.00 |
| Mar 31, 2017 | 270,000.00 |
| Dec 31, 2016 | -317,000.00 |
| Sep 30, 2016 | 62,000.00 |
| Jun 30, 2016 | 366,000.00 |
| Mar 31, 2016 | -8,000.00 |
| Dec 31, 2015 | 426,000.00 |
| Sep 30, 2015 | -52,000.00 |
| Jun 30, 2015 | 138,000.00 |
| Mar 31, 2015 | -148,000.00 |
| Dec 31, 2014 | -356,000.00 |
| Sep 30, 2014 | -34,000.00 |
| Jun 30, 2014 | -133,000.00 |
| Mar 31, 2014 | 45,000.00 |
| Dec 31, 2013 | 466,000.00 |
| Sep 30, 2013 | 134,000.00 |
| Jun 30, 2013 | 199,000.00 |
| Mar 31, 2013 | -71,000.00 |
| Dec 31, 2012 | 92,000.00 |
| Sep 30, 2012 | -82,000.00 |
| Jun 30, 2012 | 137,000.00 |
| Mar 31, 2012 | -70,000.00 |
| Dec 31, 2011 | 153,000.00 |
| Sep 30, 2011 | 156,000.00 |
| Jun 30, 2011 | 188,000.00 |
| Mar 31, 2011 | 158,000.00 |
| Dec 31, 2010 | 170,000.00 |
| Sep 30, 2010 | -12,000.00 |
| Jun 30, 2010 | -39,000.00 |